Systems and methods for treating eye diseases using retrograde blood flow
A method, device, or system for treating eye disorders or conditions, comprising restoring or increasing blood flow or blood flow rate in an artery that supplies blood to or in the eye, thereby increasing the amount of nutrient(s) that reaches the eye or a portion thereof. The invention also includes methods, devices, or systems for treating eye disorders or conditions which use reverse flow or retrograde flow structures and systems during the treatment of the eye disease.
1. A method, comprising:
inducing retrograde flow in an artery to establish induced retrograde flow and to stop antegrade flow in an ophthalmic artery of a subject;
positioning a first device within the ophthalmic artery;
treating at least one of the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery of the subject, with the first device; and
delivering the induced retrograde flow to the venous system of the subject.
2. The method of claim 1 , wherein inducing retrograde flow in the artery includes intravascularly inducing retrograde flow in the artery.
3. The method of claim 1 , wherein inducing retrograde flow in the artery causes retrograde flow in the ophthalmic artery.
4. The method of claim 1 , further including:
restoring antegrade blood flow in the ophthalmic artery.
5. The method of claim 1 , further including:
increasing nutrient delivery to the ophthalmic artery.
6. The method of claim 1 , wherein positioning the first device within the ophthalmic artery of a subject includes extending the first device through a lumen of another device located within an arterial system of the subject.
7. A method, comprising:
intravascularly introducing a first device into a subject, the subject having an ophthalmic artery with a first antegrade blood flow rate therein;
inducing retrograde blood flow in a carotid artery;
positioning the first device within the ophthalmic artery;
without the first antegrade blood flow in the ophthalmic artery, treating tissue of the ophthalmic artery or a junction of an internal carotid artery and the ophthalmic artery, via the first device; and
after treating tissue, ceasing retrograde blood flow in the carotid artery.
8. The method of claim 7 , wherein, after ceasing retrograde blood flow, the ophthalmic artery has a second antegrade blood flow rate greater than the first antegrade blood flow rate.
9. The method of claim 7 , further including increasing nutrient delivery to the ophthalmic artery.
10. The method of claim 7 , wherein treating tissue of the ophthalmic artery or the junction of the internal carotid artery and the ophthalmic artery includes removing tissue of at least one of a lesion or a blockage.
11. The method of claim 10 , wherein the inducing the retrograde blood flow includes inducing retrograde flow distal of the at least one of the lesion or the blockage.
12. The method of claim 7 , further including:
positioning a second device within a venous system of the subject; and
delivering the induced retrograde blood flow to the venous system via the second device.
13. The method of claim 7 , further including filtering the induced retrograde blood flow.
14. A method, comprising:
inducing retrograde flow in an ophthalmic artery of a subject;
positioning a first device within the ophthalmic artery of the subject; and
filtering the induced retrograde flow.
15. The method of claim 14 , further including:
positioning a second device within an internal carotid artery of the subject.
16. The method of claim 15 , wherein positioning the first device within the ophthalmic artery of the subject includes delivering the first device through a lumen of the second device.
17. The method of claim 14 , further including:
ceasing the retrograde flow in the ophthalmic artery of the subject.
18. The method of claim 14 , further including:
delivering the filtered induced retrograde flow to a venous system of the subject.
19. The method of claim 14 , wherein the inducing retrograde flow in the ophthalmic artery includes occluding an internal carotid artery of the subject.
20. The method of claim 14 , further including:
treating tissue of the ophthalmic artery or a junction of an internal carotid artery and the ophthalmic artery, via the first device.
21. A method, comprising:
positioning a first device within an ophthalmic artery of a subject, wherein the ophthalmic artery has a first antegrade blood flow rate;
inducing retrograde blood flow in a carotid artery and the ophthalmic artery;
treating tissue of the ophthalmic artery or a junction of the internal carotid artery and the ophthalmic artery, via the first device; and
ceasing retrograde blood flow in the carotid artery;
wherein after ceasing retrograde blood flow, the ophthalmic artery has a second antegrade blood flow rate greater than the first antegrade blood flow rate.
22. The method of claim 21 , wherein treating tissue of the ophthalmic artery or a junction of the internal carotid artery and the ophthalmic artery includes treating tissue of the ophthalmic artery.
23. The method of claim 22 , further comprising filtering the retrograde blood flow during the treating tissue step, wherein filtering the retrograde blood flow includes capturing emboli.
24. The method of claim 21 , wherein treating tissue of the ophthalmic artery or a junction of the internal carotid artery includes treating at least one of a complete blockage or a partial blockage of an ophthalmic artery via at least one of a stenting, an angioplasty, an atherectomy, or a drug treatment.
25. The method of claim 21 , wherein the first antegrade blood flow rate and the second antegrade blood flow rate are volumetric blood flow rates.
26. The method of claim 21 , wherein the first antegrade blood flow rate and the second antegrade blood flow rate are linear blood flow rates.
27. The method of claim 21 , wherein the second blood flow rate increases an amount of a nutrient to the eye, relative to an amount of the nutrient to the eye from the first blood flow rate, wherein the nutrient includes one or more of oxygen, hemoglobin, complement, and glucose.
28. The method of claim 21 , wherein inducing retrograde blood flow in the ophthalmic artery causes blood flow from an artery to a venous system via a connection between the artery and the venous system.
29. The method of claim 28 , wherein inducing retrograde blood flow in the ophthalmic artery includes occluding the internal carotid artery.
30. The method of claim 21 , further comprising controlling the inducing of retrograde blood flow, via a pump, a syringe, a valve, or an aspiration source.